PT-141 (Bremelanotide)

$0.00

FDA-approved as Vyleesi for acquired generalized low sexual desire causing distress in certain premenopausal women—not for men or general sexual-performance enhancement.

FDA-approved as Vyleesi for acquired generalized low sexual desire causing distress in certain premenopausal women—not for men or general sexual-performance enhancement.